Originally published In Press as doi:10.1074/jbc.M205816200 on July 16, 2002
J. Biol. Chem., Vol. 277, Issue 38, 35088-35096, September 20, 2002
Requirements for Heterodimerization between the Orphan
Nuclear Receptor Nurr1 and Retinoid X Receptors*
Paola
Sacchetti
,
Hélène
Dwornik,
Pierre
Formstecher,
Christophe
Rachez, and
Philippe
Lefebvre§
From the INSERM Unité 459, Faculté de Medecine Henri
Warembourg, 1 Place de Verdun, Lille 59045, France
Received for publication, June 12, 2002, and in revised form, July 12, 2002
 |
ABSTRACT |
The nuclear receptor nurr1 is a
transcription factor involved in the development and maintenance
of neurons synthesizing the neurotransmitter dopamine.
Although the lack of nurr1 expression has dramatic consequences for
these cells either in terms of differentiation or survival, the
mechanisms by which nurr1 controls gene transcription still remain
unclear. In the intent to understand better the modalities of action of
this nuclear receptor, we have undertaken a systematic analysis of the
transcriptional effects and DNA binding properties of nurr1 as a
monomer or when forming dimers with the different isotypes of the
retinoic X receptor (RXR). Here, we show that nurr1 acts as a gene
activator independently of RXR and through an AF2-independent
mechanism. In addition, heterodimerization with RXR is
isotype-specific, involves multiple domains in the C-terminal region of
nurr1, and requires RXR binding to DNA. RXR
-nurr1 and RXR
-nurr1
heterodimers bind direct repeat response elements and display no
specific requirements with respect to half-site spacing. However, the
retinoid responsiveness of DNA-bound heterodimers requires the
reiteration of at least three nurr1 binding sites, thereby limiting
retinoid-induced nurr1 transcriptional activity to specific direct
response elements.
 |
INTRODUCTION |
The nuclear receptor nurr1 (NR4A2) is a brain-specific
transcription factor (1), member of the superfamily of nuclear
receptors (NR)1 that plays a
major role in the development and maintenance of a specific subset of
neuronal cells. Knockout experiments have shown that absence of
nurr1 causes an abnormal development of dopamine-synthesizing neurons
of the midbrain region (2-4). Interestingly, further analysis of the
knockout mice demonstrated that early neuronal differentiation is not
affected by absence of nurr1 (5-7), whereas this factor is fundamental
for the final differentiation of mesencephalic cells and expression of
dopamine-specific marker genes like tyrosine hydroxylase, dopamine
transporter, and L-aromatic amino acid decarboxylase (3,
4). Recently, it has been shown that the human dopamine transporter
gene (8) is activated in vitro by nurr1 (9, 10) and that
nurr1 might be playing an important transcription regulatory role
in vivo as well (11).
To date, only the human dopamine transporter and tyrosine hydroxylase
genes have been shown to be regulated by nurr1 (12). However, in light
of its important role in dopaminergic phenotype maintenance and its
gene expression in several brain regions in adult tissue (13, 14), a
wider nurr1 target gene pool is conceivable. In addition, it is
necessary to characterize further the transcriptional mechanisms by
which this orphan nuclear receptor controls gene expression to identify
nurr1-regulated genes. Nurr1, like its related factors nur77 and nor1
(15), binds as a monomer to the nerve growth factor
inducible-
DNA binding sequence AAAGGTCA (NBRE (16)) and strongly
activates the expression of reporter genes bearing this sequence (10,
17). Furthermore, nurr1 also activates transcription by interacting
with the 9-cis- retinoic acid receptor (RXR (18)) and forms
heterodimers permissive to retinoids on multimerized AGGTCA response
elements (17, 19, 20). However, retinoid-mediated transcription is not
observed for natural nurr1-regulated genes containing functional NBREs in their promoter (10, 21).
RXR acts as a critical partner for several other NRs and forms either
silent or 9-cis-retinoic acid-responsive heterodimers, depending on the dimer partner (22). Characterization of the RXR-nurr1
DNA binding properties showed that RXR-nurr1 dimers bind preferentially
to DR5 response element, in a manner reminiscent of the
RXR-all-trans-retinoic acid receptor (RAR) dimer (20). However, the nurr1 C-terminal transactivation domain AF2 is required for RXR-nurr1 dimer formation (17), unlike other RXR-containing heterodimers. The exact interaction modalities among nurr1, RXR, and
their potential target recognition sequences need further analysis.
Notably, the recent identification of a brain-specific ligand for
RXR-nurr1 heterodimers (23) suggests that RXR ligands may play a
crucial role in regulating nurr1 transcriptional activity and prompts
the identification of functional target genes for this RXR-nurr1
regulatory complex.
In this study, we characterized the dimerization process between nurr1
and RXR by analyzing transcriptional activities and DNA binding
properties of these receptors in PC12 cells, a pheochromocytoma cell
line with neuronal characteristics and the ability to express nurr1
(1). Nurr1 interacted specifically with the RXR isotypes
and
,
but not
, and two regions in the C-terminal region of nurr1 are
necessary for dimerization with RXR. RXR-nurr1 heterodimers displayed
low stringency with respect to DR half-site spacing. Formation of
DNA-bound heterodimers on DR with spacing ranging from 10 to 27 bases
was detected, but these dimers were refractory to retinoid stimulation
in transcription assays. In addition, our studies reiterate the
function of nurr1 as a monomeric protein because preventing nurr1
interaction with RXR through modification of putative dimerization
interfaces did not alter its transcription activating function.
 |
EXPERIMENTAL PROCEDURES |
Plasmids--
The luciferase reporter plasmids used in transient
transfection studies were cloned by inserting one, two, or three copies of NBRE (see Fig. 1) upstream of the herpes simplex virus thymidine kinase (tk) gene minimal promoter in a pGL3-based vector (obtained from
K. Ozato). The pCMX-nurr1 and pCMX-RXR
encoding full-length mouse
nurr1 and RXR
cDNAs were obtained from R. M. Evans.
cDNAs coding for human wild type (RXR
), AF2-deleted RXR
(RXR
AF2; amino acids 1-419), and mutant RXGR subcloned into pSG5
(Stratagene, Amsterdam) have been described elsewhere (24-26). The
(DR5)3xtkLuc contains three repeats of a retinoic acid receptor
response element spaced by five base pairs. The RXR
plasmid
encoding full-length human RXR
cDNA cloned into pcDNA3 was a
kind gift of R. Polakowska. The dimerization-negative mutants,
pCMX-nurr1dim
and pSG5-RXR
dim
, and the
truncated form of nurr1, pCMX-nurr1
AF2 (amino acids 1-584), were
constructed by site-directed mutagenesis (QuikChange, Stratagene)
following the manufacturer's protocol. Specific oligonucleotides were
used to mutate nurr1 residues Lys554, Leu555,
and Leu556 into Ala (nurr1dim
(27)), RXR
residues Glu390 and Glu394 into Ala
(RXR
dim
), and to insert a stop codon at nurr1 residue
Pro584 (nurr1
AF2). All constructs were verified by
automated sequencing and restriction analysis.
Cell Culture and Transfections--
Transient transfection
studies were performed in PC12 cells, grown at 37 °C in a 5%
CO2 humidified atmosphere in Dulbecco's modified Eagle's
medium high glucose (Invitrogen) containing 5% heat-inactivated fetal
calf serum (BioWhittaker), 5% heat-inactivated horse serum (HyQ,
Logan, UT), and supplemented with 2 mM
L-glutamine, 1,000 units/ml penicillin, and 100 µg/ml
streptomycin (Invitrogen). Cells were plated in 24-well plates
(2.5 × 105 cells/well) 24 h before transfection
and transfected with 0.5 µg of plasmid DNA/well complexed with 3 µl
of LipofectAMINE (Invitrogen). Typically, cells were transfected with
50 ng of the reporter construct and 100 ng of receptor expression
vectors. A reporter gene expressing the
-galactosidase cDNA
driven by the cytomegalovirus promoter was cotransfected (10 ng) in all
experiments as an internal control for normalization of transfection
efficiency. After a 5-h incubation, the lipid/DNA mix was replaced with
fresh 2.5% serum medium containing dimethyl sulfoxide or 1 µM CD2624. Luciferase and
-galactosidase activities
were assayed 24 h later using Bright-Glo (Promega) and
Galacto-Star (Tropix, Bedford, MA) reagents, respectively, and a
LumiCount luminometer (Packard).
Western Blotting and Antibodies--
The antibody directed
against RXR
(sc-553) was obtained from Santa Cruz (Santa Cruz, CA).
The monoclonal
-actin antibody (A5441) and peroxidase-coupled
anti-rabbit IgG were purchased from Sigma and the alkaline
phosphatase-conjugated anti-mouse IgG from Promega. Proteins were
resolved on a 10% SDS-polyacrylamide gel and transferred onto
nitrocellulose membrane (Hybond-C, Amersham Biosciences).
Immunodetections were carried out using the ECL Plus (RXR
; Amersham
Biosciences) and the ECF (actin; Promega) detection systems.
Reverse Transcription-PCR--
Total RNA from cells or tissue
was isolated (RNeasy Minikit, Qiagen, Courtaboeuf, France), and 1-µg
aliquots were reverse transcribed in the presence of random primers by
Moloney murine leukemia virus reverse transcriptase (Promega) following
the manufacturer's protocol. Conditions for PCR amplifications were as
follows: 94 °C for 5 min, 30 cycles at 94 °C for 30 s,
50 °C (58 °C for nurr1 and actin) for 1 min, 72 °C for 1 min,
and a final extension at 72 °C for 7 min. Reactions were carried out
using specific primers designed based on sequences published previously
(nurr1 and actin primers as described elsewhere (10, 26), hRXR
(bp
582-898), mRXR
(bp 249-592)).
Electrophoretic Mobility Shift Assays (EMSAs)--
The following
oligonucleotides containing different NBRE repetition elements were end
labeled with [
-32P]dATP (3,000 Ci/mmol) and T4
polynucleotide kinase and used as probes:
NBRE1x, gtaccctcgagctAAAGGTCAcgctagca;
NBRE2xDR10,
gtaccgcagcagccctcgagctAAAGGTCAcgctagctAAAGGTCAa;
NBRE2xDR11,
gtaccAAAGGTCAcctcgagctAAAGGTCAcgctagctgcagcagca;
NBRE2xDR27,
gtaccAAAGGTCAcctcgagctgcagcagccgctagctAAAGGTCAa;
NBRE3x, gtaccAAAGGTCAcctcgagctAAAGGTCAcgctagctAAAGGTCAa.
Proteins were synthesized and labeled by coupled in vitro
transcription/translation in rabbit reticulocyte lysates
(TNTTM T7-coupled transcription/translation system,
Promega) and incubated in a binding buffer containing 10 mM
Tris-HCl, pH 8.0, 40 mM KCl, 7% glycerol, and 1 mM dithiothreitol. The probe and 1 µg of poly(dI·dC) were added to the reaction, and the mix was incubated on ice for 20 min. For supershift assays, 0.3 µg of nurr1-specific antibody (sc-991
X; Santa Cruz), RXR
antibody (sc-553; Santa Cruz), or anti-glutathione S-transferase IgG (sc-138; Santa Cruz) were
preincubated with the in vitro translated proteins for 15 min at room temperature before addition of the probe. Electrophoresis
was run in 0.5 × TBE on a 5.5% nondenaturing polyacrylamide gel
at 4 °C. After electrophoresis, gels were dried for autoradiography
or PhosphorImager (Molecular Dynamics) quantification.
 |
RESULTS |
Nurr1 Activates Transcription in PC12 Cells--
The
transcriptional activity of the nuclear receptor nurr1 has been
previously shown to be cell type-specific and mostly restricted to
neuronal cell types (17). In the intent to characterize the transcriptional activity of nurr1 acting as monomer or as a heterodimer with RXR, we used the rat pheochromocytoma PC12 cells because they
exhibit neuronal-like characteristics and can be stimulated to induce
expression of nurr1 (1). Thus, this cell line provides an appropriate
background to study the transcriptional mechanisms of this
brain-specific receptor.
Because the functional activity of nurr1 in these cells has not been
described previously, we tested the ability of nurr1 to induce the
expression of a luciferase reporter gene containing three canonical
nurr1 binding sites (NBRE) upstream of a tk minimal promoter
(NBRE3xtkLuc). The three NBREs introduced in the reporter vector form
direct repeats spaced by 9 (DR11) and 8 (DR10) nucleotides, respectively (Fig. 1B). Fig. 1
shows that increasing doses of nurr1 strongly activated the NBRE3x
plasmid in a dose-dependent manner, whereas nurr1 did not
affect the activity of the parental plasmid, pGL3tkLuc.

View larger version (16K):
[in this window]
[in a new window]
|
Fig. 1.
Dose-dependent activation of a
NBRE3x reporter gene by the transcription factor nurr1.
A, analysis of luciferase activity in PC12 cell extracts
transfected with 50 ng of pGL3tkLuc or a luciferase reporter plasmid
containing three NBRE binding sites (NBRE3xtkLuc) and the indicated
doses of nurr1. Luciferase activity was normalized to -galactosidase
activity, and the values are expressed as -fold induction over the
normalized basal NBRE3xtkLuc activity set to 1. Data are the means ± S.E. (bars) of a representative experiment
(n = 3), and the experiment was performed three times
with similar results. B, sequence and geometry of the NBRE3x
element.
|
|
Nurr1 Interacts Functionally with RXR Isotypes
and
but Not
--
Nurr1 can interact with RXR
and form heterodimers
responsive to retinoids (17, 19). Three forms of RXR have been
identified (28) which exhibit different tissue distributions in the
brain (29, 30) and could therefore potentially interact with nurr1 to
form distinct functional regulatory complexes in different cell types.
Thus, we were interested in testing the functional activities of the
different RXR-nurr1 dimers and compared them with the ability of nurr1
to induce reporter gene expression. Nurr1 significantly increased the
basal activity of the NBRE3x plasmid (Fig.
2A), and this activation was
enhanced further upon addition of the RXR-specific ligand (rexinoid)
CD2624, reflecting a contribution of endogenous RXRs. Overexpression of
RXR
alone had no effect on the luciferase activity of the reporter
gene, even after stimulation with CD2624. Upon cotransfection of nurr1 and RXR
, the luciferase level was only slightly enhanced compared with nurr1 alone; however, stimulation with CD2624 strongly induced (approximately 12-fold) the activity of the NBRE3x reporter gene (Fig.
2A). We then studied the ability of RXR
-nurr1 and
RXR
-nurr1 to activate the NBRE3xtkLuc construct. As expected, RXR
(Fig. 2A) and RXR
(data not shown) alone, in the presence
or absence of the rexinoid, did not induce luciferase activity above
the NBRE3x basal level. Coexpression of RXR
and nurr1 did not
significantly alter the luciferase activity level compared with nurr1
alone. Surprisingly, luciferase activity was not further enhanced upon addition of the rexinoid, suggesting a lack of functional interaction between nurr1 and RXR
(Fig. 2A). On the contrary,
cotransfection of nurr1 and RXR
enhanced luciferase activity in a
ligand-dependent manner (34-fold; Fig. 2A,
right panel). Similar results were obtained using a
different rexinoid (CD2425) and 9-cis-retinoic acid (data not shown), confirming that the effects observed are the result of
isotype-specific heterodimer formations and not ligand-specific properties. Thus, RXR
-nurr1 and RXR
-nurr1 heterodimers have similar transcriptional properties in this system, suggesting that the
isotypes
and
are potent partners of nurr1 and potential functional relays of retinoid action on nurr1-controlled pathways.

View larger version (25K):
[in this window]
[in a new window]
|
Fig. 2.
Formation of functional heterodimers between
nurr1 and isoforms and of RXR. A, analysis of luciferase activity of
PC12 cell extracts after stimulation with 1 µM CD2624, a
RXR-specific ligand. Cells were transfected with 50 ng of NBRE3xtkLuc
reporter plasmid and 100 ng of the different receptor expression
vectors, pCMX-nurr1, pSG5-hRXR , pSG5-hRXR AF2,
pcDNA3-hRXR , and pCMX-mRXR , as indicated. Results are
expressed as described in Fig. 1. DMSO, dimethyl sulfoxide.
B and C, expression of nuclear receptors used in
PC12 cells. B, 25 µg of whole cell extracts transfected
with an empty pSG5 (control) and a pSG5-hRXR expression vector was
analyzed by Western blotting with an antibody to RXR. In
vitro transcribed and translated pSG5-hRXR (TnT) and
actin were used as controls. C, total RNAs from rat midbrain
and PC12 cells were analyzed by reverse transcription-PCR for
endogenous RXR isoforms and and nurr1 transcripts. Actin was
used as an internal control, and RNA from PC12 cells transfected with
the different receptor expression vectors was used as control for
receptor overexpression.
|
|
We were interested in defining the contribution of the RXR AF2 domain
in heterodimer formation between nurr1 and RXR. To this end, we used a
RXR
AF2 mutant (25) that conserves the ability to homo- and
heterodimerize with RAR (31) but lacks the terminal 19 residues that
allow for ligand-dependent transcriptional activity. Overexpression of this mutant alone had no effect on the reporter basal
activity, and cotransfection with nurr1 evidenced a wild type-like
sensitivity to nurr1 overexpression (Fig. 2A). However, addition of the RXR ligand did not enhance luciferase expression as
observed in the wild type RXR
-nurr1. Thus, the RXR
AF2-nurr1 heterodimers are insensitive to retinoids, showing that the presence of
the AF2 domain of RXR is required for RXR
-nurr1 heterodimer response
to these ligands.
We suspected that the enhancing effects induced by the RXR ligand
CD2624 on nurr1 activity in the absence of overexpressed RXR (Fig.
2A) were because of heterodimerization of nurr1 with endogenous RXR
/
expressed in PC12 cells. Thus, we tested the presence of RXR in these cells by Western blotting assays. As shown in
Fig. 2B, PC12 cells expressed a significant amount of RXR
, and this level could be enhanced strongly upon transfection of
the RXR
expression vector. We similarly tested the levels of nurr1,
RXR
, and RXR
expression in PC12 cells by reverse
transcription-PCR because of unavailability of antibodies or
unsatisfying results obtained by Western blotting using available
antibodies. PC12 cells expressed detectable levels of RXR
mRNA
(Fig. 2C) but not of nurr1 and RXR
. After transfection
with the appropriate cDNA-encoding plasmids, we were able to detect
nurr1 as well as RXR
mRNAs and an increased RXR
expression.
Nurr1 Forms DNA-bound Heterodimers with RXR
and
--
To
understand whether the different transcriptional effects observed on
the NBRE3x reporter were the result of different receptor complexes
binding to the same DNA element, we tested the DNA binding properties
of these heterodimers by EMSA (Fig. 3).
Nurr1 was able to bind efficiently to the NBRE sites present in the 3x
element, producing a single band shift (Fig. 3A). This
interaction was specific because addition of a nurr1-specific antibody
prevented the formation of the receptor-DNA complex (compare lane
2 with lane 3). The antibody used was raised against
the N-terminal domain of nurr1 and probably interfered with DNA
binding. As expected, because of the absence of its specific DNA
response element, RXR
was not able to bind to the NBRE3x probe (Fig.
3A, lane 4). Coincubation of nurr1 and RXR
resulted in the formation of a complex of lower mobility (Fig.
3A, lane 5) indicative of the presence of
RXR
-nurr1 dimers. Once again, addition of a nurr1-specific antibody
abolished the formation of the higher mobility complex, confirming the
presence of nurr1 in this complex (lane 6).

View larger version (23K):
[in this window]
[in a new window]
|
Fig. 3.
DNA binding activities of RXR-nurr1 dimers on
an NBRE3x motif. A, DNA binding of nurr1, RXR , and
nurr1-RXR in the presence or absence of a nurr1-specific antibody.
Receptors were obtained by in vitro translation and
incubated for 15 min at room temperature with the antibody. The labeled
NBRE3x probe was then added for 20 min, and complexes were resolved on
nondenaturing 5.5% PAGE. Complexes were then visualized by
autoradiography of dried gels. B, dimerization between nurr1
and , , and forms of RXR. Receptor-DNA complexes were
obtained and visualized as in A. Lower panel,
control for RXR protein loadings used in EMSA. RXR receptors were
obtained by in vitro translation in the presence of
[35S]methionine and resolved on 10% SDS-PAGE. The gel
was dried and visualized by PhosphorImager exposure. C, RXR
AF2 is not required for dimerization with nurr1. Complexes between wt
RXR or RXR AF2 and nurr1 were preincubated with a RXR-specific
antibody for 15 min. The labeled probe was then added, and complexes
were resolved on a polyacrylamide gel. The positions of the different
complexes are indicated. The dark arrow indicates the
position of supershifted complexes.
|
|
Functional data shown in Fig. 2 suggested the formation of heterodimers
between nurr1 and RXR
and
, but not RXR
. Thus, we tested this
hypothesis by comparing the ability of RXR isotypes to form
heterodimers on this NBRE3x probe. Fig. 3B shows that coincubation of nurr1 and RXR
or nurr1 and RXR
yielded two
complexes, one having migration properties identical to nurr1 alone
(lanes 2, 3, and 5) and the other of
lower mobility, indicative of dimer formation (lanes 3 and
5). However, when nurr1 and RXR
were coincubated with the
labeled NBRE3x, only a single band was detectable which migrated
similarly to nurr1 alone (compare lane 2 with lane
4). Thus, RXR
is unable to form dimers with nurr1,
providing a molecular basis for the lack of nurr1 responsiveness to
rexinoid in the presence of RXR
.
The lack of rexinoid sensitivity of the RXR
AF2-nurr1 heterodimers
(Fig. 2A) prompted us to test the ability of the two
receptors to interact and bind DNA. Coincubation of nurr1 and
RXR
AF2 (Fig. 3C) resulted in a low mobility complex
that was supershifted in the presence of RXR antibody (lanes
5 and 6), suggesting that deletion of the RXR AF2
domain does not prevent RXR-nurr1 dimerization, but interferes only
with RXR-mediated transcription.
Nurr1 and RXR
Interact through Two Domains Present in the Ligand
Binding Domain (LBD)--
The fact that the C-terminal truncation of
RXR did not affect the heterodimerization process with nurr1 was
reminiscent of the results obtained with a truncated RXR (
387-429)
and RAR (32). Because one of the dimerization interface domains has
been localized in the LBD of receptors such as RXR and RAR (32), we
tested whether RXR-nurr1 dimers interacted through the same region.
Based on the RXR
-RAR
dimer crystallographic structure (33), amino acids in helix 9 of the RXR LBD (Glu390 and
Glu394), potentially involved in RXR
-nurr1 dimer
interaction, were mutated into Ala residues. We hypothesized that
mutations of these cardinal residues would disrupt the dimer interface
and prevent the complex from binding to NBREs. To verify our
hypothesis, we performed EMSA with in vitro translated wt
and mutant RXR. We also used a dimerization-deficient nurr1
(nurr1dim
) whose residues
Lys554-Leu555-Leu556, present in
the putative consensus dimerization interface, had been mutated to Ala
residues (27). As expected, wt nurr1 and nurr1dim
bound
the NBRE3x with similar affinities and formed a single mobility complex
(Fig. 4A, lanes 2 and 3), whereas neither wt RXR
nor the
RXR
dim
mutant bound to DNA (lanes 4 and
5). Coincubation of wt nurr1 and wt RXR
resulted in the
formation of RXR
-nurr1 heterodimers (lane 6) as confirmed
by supershift assays (see Fig. 3). On the contrary, coincubation of
nurr1 with RXR
dim
did not yield RXR-nurr1 heterodimers
(compare lane 7 with lane 2). Similar results
were obtained using the nurr1 derivative defective for dimerization,
nurr1dim
(Fig. 4A). These results thus
identify RXR
Glu390, Glu394 and nurr1
Lys554-Leu555-Leu556 as critical
contributors to heterodimer formation.

View larger version (26K):
[in this window]
[in a new window]
|
Fig. 4.
Mutations within the dimerization interface
or the DNA binding domain prevent the formation of stable heterodimers
on the NBRE3x motif. A, DNA binding of wt nurr1 and
nurr1dim mutant in the presence and absence of wt RXR
and RXR dim on the NBRE3x probe. Receptors were
obtained by in vitro translation and incubated for 20 min
with labeled NBRE3x probe. Receptor-DNA complexes were resolved on
nondenaturing 5.5% PAGE and visualized by autoradiography of dried
gels. Lanes 10 and 11, DNA binding of nurr1 AF2
mutant to the probe in the presence or absence of wt RXR .
B, absence of dimerization between nurr1 and RXGR mutant,
unable to bind NBRE motifs. Supershifting with RXR-specific antibody
did not affect band migration. Receptor-DNA complexes were obtained and
visualized as in Fig. 3. Lanes 2 and 3, nurr1
alone; lanes 4 and 5, RXR alone; lanes
6-9, RXR-nurr1 complexes.
|
|
Previously published work (17) suggested that the AF2 domain of nurr1
is necessary for RXR-nurr1 dimerization. Thus, we tested the ability of
a truncated form of nurr1 (nurr1
AF2) to heterodimerize with RXR and
bind to the NBRE3x response element (Fig. 4A, lanes
10 and 11). The nurr1
AF2 mutant was able to bind to
DNA, and the addition of RXR did not induce heterodimer formation, suggesting that the nurr1 AF2 domain is not necessary for DNA binding
of nurr1 but is required for its heterodimerization with RXR.
We were interested in determining whether RXR-nurr1 heterodimer
formation required RXR binding to the NBRE3x element. We therefore tested this potential interaction using an RXR
mutant whose P box
had been substituted for a glucocorticoid receptor P box (RXGR (26)).
The RXGR mutant can only recognize the half-site AGAACA and thus is
unable to bind to AGGTCA motifs. As predicted, the RXGR protein alone
did not bind to the NBRE3x probe (Fig. 4B, lane
1), and coincubation of RXGR with wt nurr1 resulted in the formation of a unique complex migrating similarly to nurr1 alone (Fig.
4B, lane 2). Supershift experiments showed the
absence of RXR in this complex (Fig. 4B, lane 3).
Thus, inactivation of RXR-specific interaction with the AGGTCA motif
suppressed the formation of stable RXR-nurr1 dimers.
Mutations in the LBD of Nurr1 Affect Only
Heterodimerization--
We then tested the functionality of the
different complexes observed by EMSA using transient transfection
studies. As predicted, wt RXR
and the RXR
dim
mutant
did not increase the activity of the NBRE3x reporter gene (Fig.
5) even after stimulation with CD2624.
Overexpression of nurr1 or nurr1 and RXR
induced luciferase
expression (5-fold), and, as expected, stimulation with the rexinoid
CD2624 (and others, data not shown) further enhanced gene activity
(Fig. 5; see also Fig. 2A). However, coexpression of nurr1
and the RXR
dim
mutant did not confer rexinoid
responsiveness, indicating a lack of functional interaction between
these receptors. We then tested the functional interaction between wt
RXR
and nurr1dim
. The nurr1dim
construct
was able to activate luciferase expression in the NBRE3x plasmid
(7-fold), but its activity was not enhanced further by CD2624.
Coexpression of this mutant with wt RXR
or RXR
dim
did not alter the basal activity of the NBRE3x, which was also not
responsive to the rexinoid (Fig. 5). Thus, the nurr1dim
mutant could interact functionally neither with endogenous (RXR
,
) nor overexpressed RXR
to form retinoid-responsive heterodimers. The
stronger basal activation observed with nurr1dim
compared
with wt nurr1 remains unexplained at the moment. Nurr1
AF2 was able
to bind to the NBRE3x probe (see Fig. 4, lane 10) and activated luciferase expression of the NBRE3xtkLuc plasmid (Fig. 5B), although to slightly lower levels than the wt receptor.
Coexpression of this mutant with RXR
did not reveal any functional
interaction with RXR in agreement with EMSAs showing no RXR-nurr1
AF2
interaction (Fig. 4A, lane 11). This suggests
that deletion of nurr1 AF2 domain prevents the formation of functional
RXR-nurr1 dimers without altering the functional activity of nurr1
alone.

View larger version (17K):
[in this window]
[in a new window]
|
Fig. 5.
The canonical dimerization interface of nurr1
is required for rexinoid inductibility. A, analysis of
luciferase activity of PC12 cell extracts transfected with 50 ng of
NBRE3xtkLuc reporter plasmid and 100 ng of the different wt and dim
receptor expression vectors, pCMX-nurr1, pCMX-nurr1dim ,
pSG5-hRXR , and pSG5-hRXR dim . Cells were stimulated
as described under "Experimental Procedures" with dimethyl
sulfoxide (DMSO) or 1 µM CD2624. B,
comparison of transcriptional activity between wt nurr1 and
nurr1 AF2. Luciferase activity was normalized to -galactosidase
activity, and results are expressed as described in Fig. 1.
|
|
The Presence of a DR Element Is Necessary for the Formation of
Functional Dimers--
We were then interested in comparing the
interaction of nurr1 plus or minus RXR with a single NBRE element (Fig.
6A). Nurr1 bound the NBRE1x
element, producing a single complex (lane 2), and addition
of RXR
did not alter the mobility of this complex (lane
4). We observed that the complex formation was inhibited by the
addition of the anti-nurr1 antibody (lane 5) but not
affected by the presence of anti-RXR or nonspecific antibodies
(lanes 6 and 7). From this, we concluded that
nurr1 is likely to bind stably to a single response element as a
monomeric protein.

View larger version (17K):
[in this window]
[in a new window]
|
Fig. 6.
A single NBRE element does not favor binding
of functional RXR-nurr1 heterodimers. A, DNA binding of
nurr1, RXR , and RXR -nurr1 to a single NBRE. Receptors were
obtained by in vitro translation and incubated for 15 min at
room temperature with the indicated antibodies. The labeled NBRE1x
probe was then added for 20 min, and complexes were resolved on
nondenaturing 5.5% PAGE. Complexes were then visualized by
autoradiography of dried gels. B, analysis of luciferase
activity of PC12 cell extracts transfected with 50 ng of NBRE1xtkLuc
reporter plasmid and 200 ng of pCMX-nurr1 ± 200 ng of
pSG5-hRXR . Cells were stimulated as described under "Experimental
Procedures" with dimethyl sulfoxide (DMSO) or 1 µM CD2624. Luciferase activity was normalized to
-galactosidase activity, and results are expressed as described in
Fig. 1.
|
|
The functional activity of a luciferase reporter plasmid containing a
single AAAGGTCA upstream of the tk minimal promoter (NBRE1x) was
examined. Like the NBRE3xtkLuc construct, this plasmid responded in a
dose-dependent manner to nurr1 (data not shown), albeit to
a lower extent (maximal induction ~ 4-fold). The 2-fold induction by 200 ng of nurr1 was not enhanced further upon addition of
the ligand CD2624, unlike the NBRE3x element (see Figs. 2 and 5).
Coexpression of nurr1 and RXR
did not result in increased luciferase
expression of the NBRE1x plasmid, and the addition of the RXR ligand
did not further alter luciferase level (Fig. 6B), suggesting
the absence of functional interaction between nurr1 and RXR
on this
response element. Such inhibition has been reported previously on the
NurRE proopiomelanocortin element (21) and may be a potential
squelching phenomenon because of the formation of RXR-nurr1 dimers in solution.
Low Stringency of DNA Recognition by RXR
-Nurr1
Heterodimers--
It has been shown previously that RXR
binds to
the 5'-half-site when dimerizing with nurr1 and that these dimers
exhibit strong binding to a direct repeat spaced by 5 nucleotides (DR5 (20)). Because our data suggested that RXR
-nurr1 heterodimers could
bind DNA only in the presence of multiple NBRE sites, we were
interested in identifying which two sites were bound by the receptors
on the NBRE3x probe. We used different oligonucleotides in which a
single NBRE was mutated at a time and originated response elements of
DR11, DR27, and DR10 type, respectively. The comparison between binding
properties of nurr1 to the different NBRE2x probes gave rise to
surprising results. In vitro translated nurr1 was able to
bind the three probes as monomeric protein (Fig.
7A), but unexpectedly,
coincubation of nurr1 and RXR
yielded a complex of slower mobility
than nurr1 alone on all three DR elements (lanes 3,
6, and 9), suggesting that the heterodimer can
recognize and form DNA-bound heterodimers on DR10, 11, and 27 elements.
To confirm this hypothesis, we compared the band shift pattern obtained
with NBRE3x with that obtained with NBRE2xDR27. Binding of nurr1 or nurr1 and RXR
to the NBRE3x probe yielded DNA-protein complexes of
distinct mobilities (Fig. 7B, lanes 6 and
7, and Fig. 3). The slower migrating complex was
supershifted by the RXR antibody (lane 8), confirming the
presence of RXR in this complex. Identical results were obtained using
the NBRE2xDR27 element as probe (compare lane 3 with
7 and lane 4 with 8) and the DR10 as
well as the DR11 (data not shown).

View larger version (21K):
[in this window]
[in a new window]
|
Fig. 7.
RXR -nurr1
heterodimers recognize widely spaced DR elements. A, DNA
binding of nurr1 and RXR -nurr1 to probes containing differently
spaced DR elements. Receptors were obtained by in vitro
translation, incubated for 20 min with the appropriate labeled probe
(as indicated), and complexes were then resolved on nondenaturing 5.5%
PAGE. Complexes were visualized by autoradiography of dried gels.
B, supershift assays with RXR antibody on RXR -nurr1 bound
to DR27 and NBRE3x elements. Receptor-DNA complexes were obtained and
visualized as in Fig. 3. The positions of the different complexes are
indicated.
|
|
The NBRE2x sequences were introduced in the pGL3tkLuc backbone, and
their functional activities were tested (Fig.
8). All three DR-containing elements were
activated by nurr1 in a dose-dependent manner (data not
shown) and reached maximal inductions similar to that obtained with the
NBRE3xtkLuc plasmid (Fig. 8). Overexpression of nurr1 alone, or nurr1
and RXR
, activated luciferase expression of the NBRE2x plasmids to
similar extents. Surprisingly, treatment with the rexinoid CD2624 did
not further enhance the activity of any of the three NBRE2xtkLuc
plasmids (Fig. 8), suggesting that the heterodimers formed on these
elements are not functional and are unable to transduce the retinoid
signal. In similar conditions, the (DR5) 3xtkLuc reporter
plasmid responded to retinoid stimulation similarly to the NBRE3xtkLuc,
as reported previously (21).

View larger version (14K):
[in this window]
[in a new window]
|
Fig. 8.
Widely spaced DRs are unresponsive to
rexinoid stimulation. Analysis of luciferase activity of PC12 cell
extracts transfected with 50 ng of different response element-tkLuc
reporter plasmids and 100 ng of wt nurr1 ± 100 ng of RXR .
Cells were stimulated as described under "Experimental Procedures"
with dimethyl sulfoxide (DMSO) or 1 µM CD2624.
Luciferase activity was normalized to -galactosidase activity, and
results were expressed as described in Fig. 1.
|
|
 |
DISCUSSION |
Our data show for the first time that nurr1 heterodimerizes
selectively with RXR
and RXR
, but not RXR
on the NBRE3x (Figs. 2 and 3B) as well as on a DR5 (data not shown). This
isotype-specific interaction is an important element to bear in mind
when searching for target genes for these putative transcriptional
regulatory complexes. In fact, data available on the expression of the
RXR isotypes show a different spatial distribution of these receptors in adult brain (29, 30), with high protein expression levels of RXR
concentrated in the corpus striatum, the hypothalamus, and the anterior
pituitary and a lower but more ubiquitous expression of RXR
throughout the brain (29). Consequently, based on nurr1 mRNA
localization (13, 14), the potential genes regulated by RXR-nurr1
heterodimers would be located in the olfactory bulb, specific
subregions of the cortex, and the hippocampus for RXR
and the
hypothalamus for RXR
. These predictions take into account the
important differences that have been reported between localization of
mRNAs encoding for RXR receptors and actual protein expression (29). Because such differences could be applicable to other species,
clearly further studies should be performed to characterize the protein
distributions of nurr1 and RXR isotypes in human brain, data not yet
available, to identify which brain pathways could be regulated by
retinoids. In light of the importance of nurr1 for dopaminergic cell
survival and phenotypic expression (5) and high level of expression of
the nurr1 protein in human substantia nigra (11), the absence of RXR
proteins in the mesencephalic region (29) seems an important feature to
define the functional role of nurr1 in dopaminergic pathways. This
would suggest that nurr1 regulates mesencephalic dopaminergic-specific
genes via a RXR- and retinoid-independent mechanism. This conclusion
seems supported by the fact that expression of the human dopamine
transporter gene is enhanced in the presence of nurr1, but not of
RXR
(10).
The response to retinoids of RXR-nurr1 heterodimers requires the AF2
domain of RXR (Fig. 2), suggesting that retinoid control of nurr1
pathways will require the presence of RXR. Our data show that the AF2
domain of RXR
is a requirement only for rexinoid-induced transcription and that it is not a prerequisite for RXR-nurr1 heterodimer formation, as observed by EMSA (Fig. 3C). Thus,
our data confirm that RXR is not silent in these heterodimers and that
retinoids are potential nurr1 modulators in RXR-expressing cell types.
The role of the RXR AF2 domain is different from what we and others
(17) observed for the nurr1 AF2 domain. Deletion of the nurr1 AF2
domain prevented dimerization with RXR (Fig. 4, lane 11),
suggesting that this domain has a unique function in this receptor,
unusual for NRs and for RXR-containing dimers. This conclusion had been
suggested previously but then dismissed (17) by hypothesizing that this
deletion altered the nurr1 LBD structural integrity, which in turn
affected other receptor functions, such as DNA binding. However,
truncation of nurr1 AF2 did not alter the DNA binding capacities of
nurr1 alone (Fig. 4) or its transcriptional activity (Fig. 5). In
addition, another interaction domain is located within the LBD of
nurr1, in a region described previously for other NRs as the
dimerization interface domain (32). We were able to prevent heterodimer
formation by mutating few amino acids in the LBD of nurr1 and RXR
(Figs. 4 and 5), suggesting that RXR and nurr1 interact with each other
similarly to other RXR heterodimers, such as RAR-RXR. In our hands,
neither point mutations in the LBD nor the absence of the AF2 domain
altered functional and DNA binding properties of nurr1 alone,
confirming that this receptor is a strong activator on its own, which
can act independently of its dimerization partner.
Our data demonstrate that the simultaneous binding of nurr1 and RXR to
DNA is required for the formation of stable heterodimers on DR response
elements because no RXR-nurr1 complex is detected when the RXR P box is
altered (Fig. 4B). This conclusion is strengthened further
by the lack of rexinoid responsiveness of the NBRE1x reporter gene and
the inability of RXR to associate to nurr1 bound to this monovalent
response element. Based on two-hybrid experiments in mammalian cells,
nurr1 has been reported to form rexinoid-responsive units with RXR
and thus to interact with RXR in a DNA-independent manner.
(19, 20). However, in vitro protein-protein interaction assays demonstrated that structural requirements for RXR-nurr1 interaction in the absence of DNA are distinct from those involved in
RXR-nurr1-DNA complex formation. Indeed, glutathione
S-transferase pulldown assays showed that nurr1
AF2, as
well as RXR
dim
and nurr1dim
mutants,
formed heterodimers as efficiently as their wt counterpart (data not
shown). Our data therefore suggest the inability of these receptors to
bind as dimers on a single AAAGGTCA element and favor a classical
nuclear receptor heterodimerization mechanism between these two
receptors. Thus, the target genes must contain DR elements to be
regulated by RXR-nurr1 dimer complexes.
Our studies further document that DNA binding of RXR-nurr1 dimers is
more permissive than other nuclear receptor dimers in terms of spacing
between repeated elements. Previous data showed a preference for
DNA-bound heterodimers on DR5 and DR6 elements (20); however, we
observe here the formation of heterodimers exhibiting similar binding
affinities on DR10, 11, and as far as DR27 DNA elements (Fig. 7). These
results underline a significant plasticity of LBD dimerization
interface(s) between nurr1 and RXR which allow stabilization of the
dimers on these unusual response elements. The use of two strong
dimerization interfaces makes it conceivable that the strong
protein-protein interaction would allow cooperative binding on widely
spaced elements by inducing DNA bending in the long spacer between
repeat sites.
Interestingly, rexinoid responsiveness of RXR-nurr1 heterodimers is
limited to a subset of response elements because only multimerized DR5
response elements (our data and (20)) or NBRE3x (our data and (19)) are
activated by rexinoids. Despite the interaction between these
receptors and DNA, it is plausible that RXR undergoes such important
conformational changes imposed by the geometry of the response element
that they would prevent ligand binding. This could be viewed as another
mechanism to control unwanted dimer activation, but it implicates a
different method of selection of correctly spaced response elements, at
least for these types of dimers. It remains still unclear how nurr1 and RXR can bind to the NBRE3x element forming stable and functional dimers, whereas binding to only two of the three repeats does not allow
transduction of the retinoid signal. Quite intriguingly, the
reiteration of DNA binding sites has been shown to be required for
optimal RXR-mediated transcription on the CRBP2 gene promoter and other
artificial reporter genes. Moreover, the ability of RXR to bind
cooperatively as tetramers to these reiterated RXREs is
isotype-selective, with RXR
being significantly less prone to form
such tetramers (35, 36). The ability of RXR to form dimers of dimers is
mediated notably by the AF2 activating domain (helix 11), and
deletion or mutation of this region prevents RXR tetramer formation
(37). Thus analogies of the RXR system with the RXR-nurr1 system which
we describe in this paper are striking and warrant further
investigations to elucidate the interplay of nurr1 and RXR on
reiterated response elements.
In conclusion, we have determined important new features of the
mechanism of dimerization between nurr1 and its potential transcriptional regulator partner RXR. Nurr1 interacts exclusively with
RXR
and
, and nurr1 mutants unable to heterodimerize with RXR are
still strong transactivators, suggesting that this nuclear receptor
functions through two distinct mechanisms of action which are probably
implicated in the regulation of different brain signaling pathways. The
conclusion that both receptors need to interact with DNA to form
functional complexes and that only specific DR elements can transduce
retinoid signaling will help identification of potential target genes
for these complexes in regions coexpressing the different receptors.
Because our functional data were collected in a single cell type, our
conclusions need to be extended to other neuronal cell lines. The
search for target genes warrants further studies because nurr1 is a
tissue-specific factor that could be targeted in the development of
drugs to cure severe neurodegenerative conditions, such as Parkinson's disease.
 |
ACKNOWLEDGEMENTS |
We are grateful to Pascaline Ségard for
technical assistance in reverse transcription-PCR and to Bruno Lefebvre
and Céline Brand for a critical reading of the manuscript and
important discussions. We thank K. Ozato, R. M. Evans, and R. Polakowska for providing DNAs, and U. Reichert and S. Michel for retinoids.
 |
FOOTNOTES |
*
This work was supported in part by a Marie Curie Fellowship
of the European Community Program "Improving Human Research Potential and the Socio-economic Knowledge Base" under Contract
HPMF-CT-2001-01362 (to P. S.) and by the INSERM and Association
France-Parkinson.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
Recipient of an INSERM poste vert.
§
To whom correspondence should be addressed. Tel.:
33-3-2062-6876; Fax: 33-3-2062-6884; E-mail:
p.lefebvre@lille.inserm.fr.
Published, JBC Papers in Press, July 16, 2002, DOI 10.1074/jbc.M205816200
 |
ABBREVIATIONS |
The abbreviations used are:
NR, nuclear receptor(s);
DRn, direct repeats with a spacing of
n bases;
EMSA(s), electrophoretic mobility shift assay(s);
LBD, ligand binding domain;
Luc, luciferase;
NBRE, nerve growth
factor inducible-
-binding response element;
RAR, all-trans-retinoic acid receptor;
RXR, 9-cis-retinoic acid receptor;
tk, thymidine kinase;
wt, wild
type.
 |
REFERENCES |
| 1.
|
Law, S. W.,
Conneely, O. M.,
Demayo, F. J.,
and O'Malley, B. W.
(1992)
Mol. Endocrinol.
6,
2129-2135[Abstract]
|
| 2.
|
Zetterstrom, R. H.,
Solomin, L.,
Jansson, L.,
Hoffer, B. J.,
Olson, L.,
and Perlmann, T.
(1997)
Science
276,
248-250[Abstract/Free Full Text]
|
| 3.
|
Castillo, S. O.,
Baffi, J. S.,
Palkovits, M.,
Goldstein, D. S.,
Kopin, I. J.,
Witta, J.,
Magnuson, M. A.,
and Nikodem, V. M.
(1998)
Mol. Cell Neurosci.
11,
36-46[CrossRef][Medline]
[Order article via Infotrieve]
|
| 4.
|
Saucedo-Cardenas, O.,
Quintana-Hau, J. D., Le, W. D.,
Smidt, M. P.,
Cox, J. J., De,
Mayo, F.,
Burbach, J. P.,
and Conneely, O. M.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
4013-4018[Abstract/Free Full Text]
|
| 5.
|
Wallen, A.,
Zetterstrom, R. H.,
Solomin, L.,
Arvidsson, M.,
Olson, L.,
and Perlmann, T.
(1999)
Exp. Cell Res.
253,
737-746[CrossRef][Medline]
[Order article via Infotrieve]
|
| 6.
|
Le, W.,
Conneely, O. M.,
Zou, L., He, Y.,
Saucedo-Cardenas, O.,
Jankovic, J.,
Mosier, D. R.,
and Appel, S. H.
(1999)
Exp. Neurol.
159,
451-458[CrossRef][Medline]
[Order article via Infotrieve]
|
| 7.
|
Witta, J.,
Baffi, J. S.,
Palkovits, M.,
Mezey, E.,
Castillo, S. O.,
and Nikodem, V. M.
(2000)
Brain Res. Mol. Brain Res.
84,
67-78[Medline]
[Order article via Infotrieve]
|
| 8.
|
Bannon, M. J.,
Michelhaugh, S. K.,
Wang, J.,
and Sacchetti, P.
(2001)
Eur. Neuropsychopharmacol.
11,
449-455[CrossRef][Medline]
[Order article via Infotrieve]
|
| 9.
|
Sacchetti, P.,
Brownschidle, L. A.,
Granneman, J. G.,
and Bannon, M. J.
(1999)
Brain Res. Mol. Brain Res.
74,
167-174[Medline]
[Order article via Infotrieve]
|
| 10.
|
Sacchetti, P.,
Mitchell, T. R.,
Granneman, J. G.,
and Bannon, M. J.
(2001)
J. Neurochem.
76,
1565-1572[CrossRef][Medline]
[Order article via Infotrieve]
|
| 11.
|
Bannon, M. J.,
Pruetz, B.,
Manning-Bog, A. B.,
Whitty, C. J.,
Michelhaugh, S. K.,
Sacchetti, P.,
Granneman, J. G.,
Mash, D. C.,
and Schmidt, C. J.
(2002)
Proc. Natl. Acad. Sci. U. S. A.
99,
6382-6385[Abstract/Free Full Text]
|
| 12.
|
Sakurada, K.,
Ohshima-Sakurada, M.,
Palmer, T. D.,
and Gage, F. H.
(1999)
Development
126,
4017-4026[Abstract]
|
| 13.
|
Xiao, Q.,
Castillo, S. O.,
and Nikodem, V. M.
(1996)
Neuroscience
75,
221-230[CrossRef][Medline]
[Order article via Infotrieve]
|
| 14.
|
Zetterstrom, R. H.,
Williams, R.,
Perlmann, T.,
and Olson, L.
(1996)
Brain Res. Mol. Brain Res.
41,
111-120[Medline]
[Order article via Infotrieve]
|
| 15.
|
Maruyama, K.,
Tsukada, T.,
Ohkura, N.,
Bandoh, S.,
Hosono, T.,
and Yamaguchi, K.
(1998)
Int. J. Oncol.
12,
1237-1243[Medline]
[Order article via Infotrieve]
|
| 16.
|
Wilson, T. E.,
Paulsen, R. E.,
Padgett, K. A.,
and Milbrandt, J.
(1992)
Science
256,
107-110[Abstract/Free Full Text]
|
| 17.
|
Castro, D. S.,
Arvidsson, M.,
Bondesson, B. M.,
and Perlmann, T.
(1999)
J. Biol. Chem.
274,
37483-37490[Abstract/Free Full Text]
|
| 18.
|
Mangelsdorf, D. J.,
Ong, E. S.,
Dyck, J. A.,
and Evans, R. M.
(1990)
Nature
345,
224-229[CrossRef][Medline]
[Order article via Infotrieve]
|
| 19.
|
Forman, B. M.,
Umesono, K.,
Chen, J.,
and Evans, R. M.
(1995)
Cell
81,
541-550[CrossRef][Medline]
[Order article via Infotrieve]
|
| 20.
|
Perlmann, T.,
and Jansson, L.
(1995)
Genes Dev.
9,
769-782[Abstract/Free Full Text]
|
| 21.
|
Maira, M.,
Martens, C.,
Philips, A.,
and Drouin, J.
(1999)
Mol. Cell. Biol.
19,
7549-7557[Abstract/Free Full Text]
|
| 22.
|
Mangelsdorf, D. J.,
and Evans, R. M.
(1995)
Cell
83,
841-850[CrossRef][Medline]
[Order article via Infotrieve]
|
| 23.
|
de Urquiza, A. M.,
Liu, S.,
Sjoberg, M.,
Zetterstrom, R. H.,
Griffiths, W.,
Sjovall, J.,
and Perlmann, T.
(2000)
Science
290,
2140-2144[Abstract/Free Full Text]
|
| 24.
|
Rachez, C.,
Sautière, P.,
Formstecher, P.,
and Lefebvre, P.
(1996)
J. Biol. Chem.
271,
17996-18006[Abstract/Free Full Text]
|
| 25.
|
Mouchon, A.,
Delmotte, M.-H.,
Formstecher, P.,
and Lefebvre, P.
(1999)
Mol. Cell. Biol.
19,
3073-3085[Abstract/Free Full Text]
|
| 26.
|
Depoix, C.,
Delmotte, M. H.,
Formstecher, P.,
and Lefebvre, P.
(2001)
J. Biol. Chem.
276,
9452-9459[Abstract/Free Full Text]
|
| 27.
|
Castro, D. S.,
Hermanson, E.,
Joseph, B.,
Wallen, A.,
Aarnisalo, P.,
Heller, A.,
and Perlmann, T.
(2001)
J. Biol. Chem.
276,
43277-43284[Abstract/Free Full Text]
|
| 28.
|
Mangelsdorf, D. J.,
Borgmeyer, U.,
Heyman, R. A.,
Zhou, J. Y.,
Ong, E. S.,
Oro, A. E.,
Kakizuka, A.,
and Evans, R. M.
(1992)
Genes Dev.
6,
329-344[Abstract/Free Full Text]
|
| 29.
|
Krezel, W.,
Kastner, P.,
and Chambon, P.
(1999)
Neuroscience
89,
1291-1300[CrossRef][Medline]
[Order article via Infotrieve]
|
| 30.
|
Zetterstrom, R. H.,
Lindqvist, E.,
Mata, D. U.,
Tomac, A.,
Eriksson, U.,
Perlmann, T.,
and Olson, L.
(1999)
Eur. J. Neurosci.
11,
407-416[CrossRef][Medline]
[Order article via Infotrieve]
|
| 31.
|
Zhang, X. K.,
Hoffmann, B.,
Tran, P. B. V.,
Graupner, G.,
and Pfahl, M.
(1992)
Nature
355,
441-446[CrossRef][Medline]
[Order article via Infotrieve]
|
| 32.
|
Perlmann, T.,
Umesono, K.,
Rangarajan, P. N.,
Forman, B. M.,
and Evans, R. M.
(1996)
Mol. Endocrinol.
10,
958-966[Abstract]
|
| 33.
|
Bourguet, W.,
Vivat, V.,
Wurtz, J. M.,
Chambon, P.,
Gronemeyer, H.,
and Moras, D.
(2000)
Mol. Cell
5,
289-298[CrossRef][Medline]
[Order article via Infotrieve]
|
| 34.
| Deleted in proof
|
| 35.
|
Lin, B. C.,
Wong, C. W.,
Chen, H. W.,
and Privalsky, M. L.
(1997)
J. Biol. Chem.
272,
9860-9867[Abstract/Free Full Text]
|
| 36.
|
Chen, H.,
and Privalsky, M. L.
(1995)
Proc. Natl. Acad. Sci. U. S. A.
92,
422-426[Abstract/Free Full Text]
|
| 37.
|
Gampe, R. T.,
Montana, V. G.,
Lambert, M. H.,
Wisely, G. B.,
Milburn, M. V.,
and Xu, H. E.
(2000)
Genes Dev.
14,
2229-2241[Abstract/Free Full Text]
|
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike
Complore
Connotea
Del.icio.us